Hyperphosphorylation of PRAS40, resulting in dissociation from mTORC1 and enhanced mTOR activation, has been found in a variety of cancers, including melanoma, prostate cancer, stomach cancer, and non‐small‐cell lung cancer (Lv et al., 2017). This evidence concerns the gene MTOR and cancer.